New Delhi, Oct 1 (PTI) Zydus Lifesciences on Saturday said it has received approval from the US health regulator to market Sildenafil for oral suspension, used to treat pulmonary hypertension, in the American market.

The company has received approval from the US Food and Drug Administration (USFDA) to market the product, the drug maker said in a statement.

Also Read | 5G in India: Case Studies by Reliance Jio, Airtel and Vodafone Idea To Be Unveiled by PM Narendra Modi.

Sildenafil for oral suspension is used to treat high blood pressure in the lungs (pulmonary hypertension). It works by relaxing and widening the blood vessels in lungs which allows the blood to flow more easily.

Decreasing high blood pressure in the lungs allows the heart and lungs to work better and improves ability to exercise.

Also Read | 'Make 6 Airbags Mandatory Only When 85% People Start Wearing Rear Seat Belts', Says International Road Federation.

Zydus said the drug will be manufactured at its Baddi-based manufacturing plant.

As per IQVIA data, Sildenafil for oral duspension had annual sales of USD 65 million in the US.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)